Roger L. Waite

1.3k total citations
29 papers, 756 citations indexed

About

Roger L. Waite is a scholar working on Physiology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Roger L. Waite has authored 29 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Roger L. Waite's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Pain Mechanisms and Treatments (5 papers). Roger L. Waite is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Pain Mechanisms and Treatments (5 papers). Roger L. Waite collaborates with scholars based in United States, Taiwan and Israel. Roger L. Waite's co-authors include Thomas J.H. Chen, Eric R. Braverman, Kenneth Blum, Bernard W. Downs, Mallory Kerner, Seth H. Blum, John Giordano, Marlene Oscar‐Berman, Nicholas A. DiNubile and Patrick Rhoades and has published in prestigious journals such as Journal of Orthopaedic Research®, Molecular Neurobiology and BMC Musculoskeletal Disorders.

In The Last Decade

Roger L. Waite

27 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger L. Waite United States 18 341 282 180 175 148 29 756
Mallory Kerner United States 16 252 0.7× 221 0.8× 137 0.8× 137 0.8× 113 0.8× 24 628
Seth H. Blum United States 14 247 0.7× 214 0.8× 126 0.7× 116 0.7× 118 0.8× 23 546
Andrea Dlugos United States 14 265 0.8× 105 0.4× 221 1.2× 135 0.8× 71 0.5× 17 731
Ruth E. Blackburn-Munro United Kingdom 7 229 0.7× 147 0.5× 147 0.8× 110 0.6× 255 1.7× 8 974
Jean-Lud Cadet United States 8 401 1.2× 119 0.4× 233 1.3× 307 1.8× 102 0.7× 8 902
Guillaume Perret Switzerland 7 609 1.8× 131 0.5× 132 0.7× 250 1.4× 124 0.8× 10 1.2k
Panayotis K. Thanos United States 12 461 1.4× 160 0.6× 130 0.7× 280 1.6× 177 1.2× 24 996
Maryna Polyakova Germany 13 204 0.6× 258 0.9× 111 0.6× 248 1.4× 86 0.6× 17 885
Jane E. Magnusson Canada 15 207 0.6× 179 0.6× 80 0.4× 144 0.8× 260 1.8× 20 744
L. Sanjay Nandam Australia 14 218 0.6× 241 0.9× 67 0.4× 344 2.0× 78 0.5× 14 892

Countries citing papers authored by Roger L. Waite

Since Specialization
Citations

This map shows the geographic impact of Roger L. Waite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Waite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Waite more than expected).

Fields of papers citing papers by Roger L. Waite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Waite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Waite. The network helps show where Roger L. Waite may publish in the future.

Co-authorship network of co-authors of Roger L. Waite

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Waite. A scholar is included among the top collaborators of Roger L. Waite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Waite. Roger L. Waite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blum, Kenneth, Roger L. Waite, Seth H. Blum, et al.. (2014). Hypothesizing “Reward” Gene Polymorphisms May Predict High Rates of Injury and Addiction in the Workforce: A Nutrient and Electrotherapeutic Based Solution. Health. 6(16). 2261–2285. 1 indexed citations
2.
McLaughlin, Thomas, Marlene Oscar‐Berman, Thomas Simpatico, et al.. (2013). Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT). Journal of Behavioral Addictions. 2(2). 117–124. 20 indexed citations
3.
Bowirrat, Abdalla, Thomas J.H. Chen, Marlene Oscar‐Berman, et al.. (2012). Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment?. Molecular Neurobiology. 45(2). 298–313. 22 indexed citations
4.
Chen, Thomas J.H., Kenneth Blum, Amanda LC Chen, et al.. (2011). Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map. Journal of Psychoactive Drugs. 43(2). 108–127. 35 indexed citations
5.
Smith, Thomas L., Michael F. Callahan, Kenneth Blum, et al.. (2011). H-Wave® effects on blood flow and angiogenesis in longitudinal studies in rats.. PubMed. 20(4). 255–9. 8 indexed citations
6.
Bowirrat, Abdalla, Thomas J.H. Chen, Kenneth Blum, et al.. (2010). Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Current Neuropharmacology. 8(4). 335–358. 45 indexed citations
7.
Blum, Kenneth, Thomas J.H. Chen, Siobhan Morse, et al.. (2010). Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2. Postgraduate Medicine. 122(6). 214–226. 71 indexed citations
8.
9.
Braverman, Eric R., Thomas J.H. Chen, Amanda LC Chen, et al.. (2009). Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender. BMC Research Notes. 2(1). 126–126. 10 indexed citations
10.
Blum, Kenneth, Thomas J.H. Chen, Margaret Madigan, et al.. (2009). Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). Medical Hypotheses. 74(3). 513–520. 40 indexed citations
11.
Blum, Kenneth, Abdalla Bowirrat, Roger L. Waite, et al.. (2009). Putative targeting of Dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex™ Variant (KB220): Clinical trial showing anti-anxiety effects. 15 indexed citations
12.
13.
Chen, Amanda LC, Thomas J.H. Chen, Roger L. Waite, et al.. (2008). Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Medical Hypotheses. 72(1). 14–22. 36 indexed citations
14.
Blum, Kenneth, Thomas J.H. Chen, Eric R. Braverman, et al.. (2008). Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theoretical Biology and Medical Modelling. 5(1). 24–24. 112 indexed citations
15.
Blum, Kenneth, Amanda LC Chen, Thomas J.H. Chen, et al.. (2008). LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Advances in Therapy. 25(9). 894–913. 41 indexed citations
16.
Blum, Kenneth, Thomas J.H. Chen, William B. Downs, et al.. (2008). A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics. 12(2). 371–382. 23 indexed citations
17.
Blum, Kenneth, Amanda LC Chen, Thomas J.H. Chen, et al.. (2008). The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Advances in Therapy. 25(7). 644–657. 17 indexed citations
18.
Chen, Thomas J.H., Kenneth Blum, Roger L. Waite, et al.. (2007). Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome. Advances in Therapy. 24(2). 402–414. 25 indexed citations
19.
20.
Blum, Kenneth, Nicholas A. DiNubile, Thomas J.H. Chen, et al.. (2006). H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study. Advances in Therapy. 23(3). 446–455. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mallory Kerner Breakdown of academic impact, for papers by Seth H. Blum Breakdown of academic impact, for papers by Andrea Dlugos Breakdown of academic impact, for papers by Ruth E. Blackburn-Munro Breakdown of academic impact, for papers by Jean-Lud Cadet Breakdown of academic impact, for papers by Guillaume Perret Breakdown of academic impact, for papers by Panayotis K. Thanos Breakdown of academic impact, for papers by Maryna Polyakova Breakdown of academic impact, for papers by Jane E. Magnusson Breakdown of academic impact, for papers by L. Sanjay Nandam
Rankless by CCL
2026